Rankings
▼
Calendar
HRTX (Heron Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
Mkt Cap
$162M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$155M
Net Income (TTM)
-$20M
EPS (TTM)
-$0.12
Free Cash Flow (TTM)
-$28M
Gross Margin
73.3%
Op. Margin
-1.6%
Net Margin
-13.0%
FCF Margin
-18.0%
P/S Ratio (TTM)
1.0x
P/E Ratio (TTM)
—
YoY Rev Growth
+7.4%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$30M
$13M
-$33M
Q2 23
$32M
$12M
-$42M
Q3 23
$31M
$13M
-$25M
Q4 23
$34M
$24M
-$10M
Q1 24
$35M
$26M
-$5M
Q2 24
$36M
$26M
-$6M
Q3 24
$33M
$23M
-$4M
Q4 24
$41M
$31M
$4M
Q1 25
$39M
$30M
$3M
Q2 25
$37M
$27M
-$2M
Q3 25
$38M
$23M
-$4M
Q4 25
$41M
$33M
$38K
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.4x
—
Q2 23
1.4x
—
Q3 23
1.3x
—
Q4 23
1.3x
—
Q1 24
1.2x
—
Q2 24
1.2x
—
Q3 24
1.2x
—
Q4 24
1.1x
—
Q1 25
1.1x
—
Q2 25
1.1x
—
Q3 25
1.0x
—
Q4 25
1.0x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$25M
-$25M
Q2 23
-$27M
-$27M
Q3 23
-$9M
-$10M
Q4 23
$2M
$2M
Q1 24
-$10M
-$10M
Q2 24
-$5M
-$5M
Q3 24
$3M
$3M
Q4 24
-$12M
-$12M
Q1 25
-$9M
-$9M
Q2 25
-$11M
-$11M
Q3 25
$1M
$1M
Q4 25
-$9M
-$9M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$224K
Q2 23
$278K
Q3 23
$793K
Q4 23
$250K
Q1 24
$0
Q2 24
$637K
Q3 24
$431K
Q4 24
$638K
Q1 25
$109K
Q2 25
$208K
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+26.3%
-27.4%
Q2 23
+15.0%
-3.8%
Q3 23
+18.4%
-17.6%
Q4 23
+14.0%
-11.8%
Q1 24
+17.1%
-37.0%
Q2 24
+13.4%
-42.7%
Q3 24
+4.4%
-33.9%
Q4 24
+19.1%
-17.6%
Q1 25
+12.2%
-9.4%
Q2 25
+3.3%
-8.6%
Q3 25
+16.5%
+13.5%
Q4 25
-0.5%
+10.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$8M
26.8%
Q2 23
$14M
43.8%
Q3 23
$7M
21.3%
Q4 23
$4M
12.6%
Q1 24
$3M
9.7%
Q2 24
$5M
12.7%
Q3 24
$3M
8.3%
Q4 24
$2M
5.6%
Q1 25
$3M
6.5%
Q2 25
$3M
7.5%
Q3 25
$3M
7.5%
Q4 25
$2M
5.4%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$9M
$16M
$21M
Q2 23
$13M
$20M
$21M
Q3 23
$14M
$12M
$13M
Q4 23
$11M
$11M
$12M
Q1 24
$5M
$15M
$11M
Q2 24
$4M
$14M
$14M
Q3 24
$4M
$12M
$11M
Q4 24
$3M
$12M
$11M
Q1 25
$2M
$13M
$12M
Q2 25
$3M
$14M
$12M
Q3 25
$3M
$14M
$13M
Q4 25
$4M
$13M
$12M
marketcaparena.com
Revenue Segments
C I N V A N T I
S U S T O L
Z Y N R E L E F
Quarter
C I N V A N T I
S U S T O L
Z Y N R E L E F
Q1 23
$23M
$3M
$4M
Q2 23
$24M
$3M
$4M
Q1 24
$26M
$4M
$5M
Q2 24
$25M
$4M
$6M
Q3 24
$23M
$3M
$6M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$27M
$33M
$60M
Q2 23
$13M
$20M
$33M
Q3 23
$35M
$43M
$77M
Q4 23
$29M
$52M
$80M
Q1 24
$20M
$51M
$72M
Q2 24
$18M
$49M
$67M
Q3 24
$26M
$45M
$71M
Q4 24
$26M
$33M
$59M
Q1 25
$19M
$31M
$51M
Q2 25
$17M
$24M
$41M
Q3 25
$43M
$12M
$55M
Q4 25
$29M
$18M
$47M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
119M
+0.1%
Q2 23
120M
+0.4%
Q3 23
145M
+21.1%
Q4 23
150M
+3.7%
Q1 24
151M
+0.6%
Q2 24
152M
+0.7%
Q3 24
153M
+0.3%
Q4 24
153M
+0.2%
Q1 25
153M
+0.2%
Q2 25
154M
+0.3%
Q3 25
170M
+10.6%
Q4 25
167M
-2.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
59
FY 15
$0
148
FY 16
$9K
139
FY 17
$212K
145
FY 18
$391K
198
FY 19
$632K
231
FY 20
$397K
223
FY 21
$286K
302
FY 22
$530K
203
FY 23
$1M
126
FY 24
$1M
122
FY 25
$1M
128
marketcaparena.com